Comparison of the Association Between Goal-Directed Planning and Self-reported Compulsivity vs Obsessive-Compulsive Disorder Diagnosis.


Journal

JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550

Informations de publication

Date de publication:
01 01 2020
Historique:
pubmed: 10 10 2019
medline: 3 2 2021
entrez: 10 10 2019
Statut: ppublish

Résumé

Dimensional definitions of transdiagnostic mental health problems have been suggested as an alternative to categorical diagnoses, having the advantage of capturing heterogeneity within diagnostic categories and similarity across them and bridging more naturally psychological and neural substrates. To examine whether a self-reported compulsivity dimension has a stronger association with goal-directed and related higher-order cognitive deficits compared with a diagnosis of obsessive-compulsive disorder (OCD). In this cross-sectional study, patients with OCD and/or generalized anxiety disorder (GAD) from across the United States completed a telephone-based diagnostic interview by a trained rater, internet-based cognitive testing, and self-reported clinical assessments from October 8, 2015, to October 1, 2017. Follow-up data were collected to test for replicability. Performance was measured on a test of goal-directed planning and cognitive flexibility (Wisconsin Card Sorting Test [WCST]) and a test of abstract reasoning. Clinical variables included DSM-5 diagnosis of OCD and GAD and 3 psychiatric symptom dimensions (general distress, compulsivity, and obsessionality) derived from a factor analysis. Of 285 individuals in the analysis (mean [SD] age, 32 [12] years; age range, 18-77 years; 219 [76.8%] female), 111 had OCD; 82, GAD; and 92, OCD and GAD. A diagnosis of OCD was not associated with goal-directed performance compared with GAD at baseline (β [SE], -0.02 [0.02]; P = .18). In contrast, a compulsivity dimension was negatively associated with goal-directed performance (β [SE], -0.05 [0.02]; P = .003). Results for abstract reasoning task and WCST mirrored this pattern; the compulsivity dimension was associated with abstract reasoning (β [SE], 2.99 [0.63]; P < .001) and several indicators of WCST performance (eg, categories completed: β [SE], -0.57 [0.09]; P < .001), whereas OCD diagnosis was not (abstract reasoning: β [SE], 0.39 [0.66]; P = .56; categories completed: β [SE], -0.09 [0.10]; P = .38). Other symptom dimensions relevant to OCD, obsessionality, and general distress had no reliable association with goal-directed performance, WCST, or abstract reasoning. Obsessionality had a positive association with requiring more trials to reach the first category on the WCST at baseline (β [SE], 2.92 [1.39]; P = .04), and general distress was associated with impaired goal-directed performance at baseline (β [SE],-0.04 [0.02]; P = .01). However, unlike the key results of this study, neither survived correction for multiple comparisons or was replicated at follow-up testing. Deficits in goal-directed planning in OCD may be more strongly associated with a compulsivity dimension than with OCD diagnosis. This result may have implications for research assessing the association between brain mechanisms and clinical manifestations and for understanding the structure of mental illness.

Identifiants

pubmed: 31596434
pii: 2752264
doi: 10.1001/jamapsychiatry.2019.2998
pmc: PMC6802255
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-85

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH100607
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Psychoneuroendocrinology. 2010 Aug;35(7):977-86
pubmed: 20071096
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Behav Res Ther. 2004 Apr;42(4):385-96
pubmed: 14998733
J Neurosci. 2009 Jun 3;29(22):7191-8
pubmed: 19494141
Am J Psychiatry. 2011 Jul;168(7):718-26
pubmed: 21572165
J Nerv Ment Dis. 2013 Dec;201(12):1007-20
pubmed: 24284634
JAMA Psychiatry. 2018 Feb 1;75(2):201-209
pubmed: 29197929
Nat Med. 2017 Jan;23(1):28-38
pubmed: 27918562
Nat Neurosci. 2005 Dec;8(12):1704-11
pubmed: 16286932
Nat Neurosci. 2005 Nov;8(11):1481-9
pubmed: 16251991
Cogn Psychol. 1997 Jun;33(1):43-63
pubmed: 9212721
PLoS One. 2014 Apr 11;9(4):e94778
pubmed: 24728288
Neuron. 2000 Nov;28(2):343-7
pubmed: 11144344
Biol Psychiatry. 2015 Jan 15;77(2):187-95
pubmed: 25062683
Philos Trans R Soc Lond B Biol Sci. 2014 Nov 5;369(1655):
pubmed: 25267818
Neuron. 2016 Jul 6;91(1):19-23
pubmed: 27387647
Soc Psychiatry Psychiatr Epidemiol. 2014 Oct;49(10):1677-89
pubmed: 24632782
Science. 2016 Jun 17;352(6292):1468-71
pubmed: 27313048
Cogn Psychol. 2000 Aug;41(1):1-48
pubmed: 10945921
Nat Neurosci. 2015 May;18(5):767-72
pubmed: 25799041
Neurosci Biobehav Rev. 2014 May;42:180-92
pubmed: 24568942
J Neurosci. 2016 Jan 27;36(4):1211-22
pubmed: 26818509
Lancet Psychiatry. 2016 Mar;3(3):243-50
pubmed: 26803397
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
pubmed: 15939839
Psychoneuroendocrinology. 2015 Mar;53:268-80
pubmed: 25662093
Neuropsychol Rev. 2018 Mar;28(1):111-120
pubmed: 28864868
Nat Rev Neurosci. 2007 Sep;8(9):725-32
pubmed: 17704814
Psychol Assess. 2002 Dec;14(4):485-96
pubmed: 12501574
Cogn Neuropsychiatry. 2006 Mar;11(2):156-76
pubmed: 16537240
CNS Spectr. 2014 Feb;19(1):69-89
pubmed: 24512640
Annu Rev Clin Psychol. 2010;6:155-79
pubmed: 17716032
Behav Res Ther. 2018 Dec;111:19-26
pubmed: 30273768
Neuroimage Clin. 2019;22:101796
pubmed: 30935858
Psychol Med. 2014 Apr;44(6):1121-30
pubmed: 23866289
Neuron. 2012 Aug 9;75(3):418-24
pubmed: 22884326
Biol Psychiatry. 2018 Sep 15;84(6):443-451
pubmed: 29458997
Biol Psychiatry. 2014 Apr 15;75(8):639-46
pubmed: 23452663
Biol Psychiatry. 2019 Mar 1;85(5):425-433
pubmed: 30077331
Psychol Med. 2017 Jul;47(9):1528-1548
pubmed: 28343453
Elife. 2016 Mar 01;5:
pubmed: 26928075
Mol Psychiatry. 2015 Mar;20(3):345-52
pubmed: 24840709
Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):20941-6
pubmed: 24324166
Am J Psychiatry. 2015 Mar 1;172(3):284-93
pubmed: 25526600
Autism Res. 2016 Dec;9(12):1285-1293
pubmed: 26999793
J Affect Disord. 2015 Feb 1;172:96-102
pubmed: 25451401
Biol Psychiatry. 2014 Apr 15;75(8):631-8
pubmed: 23510580
Arch Gen Psychiatry. 1994 May;51(5):355-64
pubmed: 8179459
J Abnorm Psychol. 2013 Aug;122(3):928-37
pubmed: 24016027
World Psychiatry. 2011 Jun;10(2):138-51
pubmed: 21633691
Neuron. 2011 Mar 24;69(6):1204-15
pubmed: 21435563
Cortex. 1976 Dec;12(4):313-24
pubmed: 1009768
PLoS One. 2017 Jul 19;12(7):e0180588
pubmed: 28723943
Neuron. 2013 Oct 16;80(2):312-25
pubmed: 24139036
J Abnorm Psychol. 2010 Nov;119(4):631-9
pubmed: 20939653
Cogn Affect Behav Neurosci. 2015 Sep;15(3):523-36
pubmed: 25801925
JAMA. 2003 Jun 18;289(23):3095-105
pubmed: 12813115

Auteurs

Claire M Gillan (CM)

School of Psychology, Trinity College Institute of Neuroscience and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.

Eyal Kalanthroff (E)

Department of Psychology, The Hebrew University of Jerusalem, Mount Scopus, Israel.

Michael Evans (M)

Department of Psychology, New York University, New York.

Hilary M Weingarden (HM)

Department of Psychiatry, Massachusetts General Hospital, Boston.
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Ryan J Jacoby (RJ)

Department of Psychiatry, Massachusetts General Hospital, Boston.
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Marina Gershkovich (M)

Department of Psychiatry, Columbia Irving University Medical Center, New York, New York.
New York State Psychiatric Institute, New York.

Ivar Snorrason (I)

Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts.

Raphael Campeas (R)

Department of Psychiatry, Columbia Irving University Medical Center, New York, New York.
New York State Psychiatric Institute, New York.

Cynthia Cervoni (C)

Department of Psychiatry, Stony Brook University, Stony Brook, New York.

Nicholas Charles Crimarco (NC)

Department of Psychiatry, Columbia Irving University Medical Center, New York, New York.

Yosef Sokol (Y)

VISN 2 Mental Illness Research Education and Clinical Centers, New York, New York.
James J. Peters Veterans Affairs Medical Center, Bronx, New York.
Icahn School of Medicine at Mount Sinai, New York, New York.

Sarah L Garnaat (SL)

Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Butler Hospital, Providence, Rhode Island.

Nicole C R McLaughlin (NCR)

Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Butler Hospital, Providence, Rhode Island.

Elizabeth A Phelps (EA)

Department of Psychology, Harvard University, Cambridge, Massachusetts.

Anthony Pinto (A)

Department of Psychiatry, Hofstra Northwell School of Medicine, Hempstead, New York.

Christina L Boisseau (CL)

Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Sabine Wilhelm (S)

Department of Psychiatry, Massachusetts General Hospital, Boston.
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Nathaniel D Daw (ND)

Princeton Neuroscience Institute, Department of Psychology, Princeton University, Princeton, New Jersey.

H B Simpson (HB)

Department of Psychiatry, Columbia Irving University Medical Center, New York, New York.
New York State Psychiatric Institute, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH